Health
Related: About this forumAccording to Harvard Scientists, Lithium May Be the Key to Stopping Alzheimer's
Un-clickbaited the headline.
https://scitechdaily.com/according-to-harvard-scientists-this-missing-nutrient-may-be-the-key-to-stopping-alzheimers/
What sets off the earliest chain of events that leads to Alzheimers disease? And why do some people who show Alzheimers-like brain changes never progress to dementia? These unresolved questions have challenged scientists for decades.
Researchers at Harvard Medical School now believe they may have an explanation: a deficiency of lithium in the brain.
Their study, published on August 6 in Nature, demonstrates for the first time that lithium is naturally present in the brain, where it protects against neurodegeneration and supports the normal functioning of all major brain cell types. The findings a decade in the making draw on mouse experiments as well as analyses of human brain tissue and blood samples from people at different stages of cognitive health.
Open-access paper.
Abstract:
https://www.nature.com/articles/s41586-025-09335-x
PDF (34 Megabytes )
https://www.nature.com/articles/s41586-025-09335-x.pdf

Bayard
(26,762 posts)I worry about my own noodle because of family history. Now, if they can turn this into a practical application........
Thanks for posting, Usonian.
ShepKat
(495 posts)also helps with the downside of methylphenidate use. Decreasing the body's urge to take more
mwooldri
(10,697 posts)Now I'm not a doctor but I presume there would be a blood test for lithium? And that a "normal" range is known? And that I suppose folks could ask for this blood test from their GP and if low get some kind of supplement? Nothing like the kind of doses people being treated for bipolar get of course.
Seems to be good news, and thus something that we can do to help prevent Alzheimer's.
Interesting piece. I still have to read one of the more intriguing abstracts I came across on Lithium in recent years:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8190433/pdf/41598_2021_Article_91388.pdf
Hadi Zadeh‑Haghigh & Christoph Simon
It is known that bipolar disorder and its lithium treatment involve the modulation of oxidative
stress. Moreover, it has been observed that lithiums effects are isotope-dependent. Based on these findings, here we propose that lithium exerts its effects by influencing the recombination dynamics of a naturally occurring radical pair involving oxygen.
We develop a simple model inspired by the
radical-pair mechanism in cryptochrome in the context of avian magnetoreception and xenon-induced anesthesia. Our model reproduces the observed isotopic dependence in the lithium treatment of hyperactivity in rats. It predicts a magnetic-field dependence of the effectiveness of lithium, which provides one potential experimental test of our hypothesis. Our findings show that Nature might harness quantum entanglement for the brains cognitive processes.
I have been on medical marijuana since late 2022 and since Dec 2024 (couldnt see weathering a second Trump term any other way), this awake medication: Diphenylmethyl-sulfinylacetamide.
Marijuana keeps me away from the occasional spree of overindulgence in alcohol, a known carcinogen. And I am interested in any potential health benefits wrt cancer, Alzheimers etc.
I dont have a very good memory and never did. I internalized (somewhat fatuously) long ago that problem solving is more important than memorization. However, as problems become harder and more complex, you certainly need memory.
I found this article notable that way:
https://www.salk.edu/news-release/active-ingredient-in-cannabis-protects-aging-brain-cells/
Active ingredient in cannabis protects aging brain cells
Salk researchers find cannabinol preserves mitochondrial function and prevents oxidative damage to cells
LA JOLLADecades of research on medical cannabis has focused on the compounds THC and CBD in clinical applications. But less is known about the therapeutic properties of cannabinol (CBN). Now, a new study by Salk scientists shows how CBN can protect nerve cells from oxidative damage, a major pathway to cell death. The findings, published online January 6, 2022, in the journal Free Radical Biology and Medicine, suggest CBN has the potential for treating age-related neurodegenerative diseases, like Alzheimers.
Weve found that cannabinol protects neurons from oxidative stress and cell death, two of the major contributors to Alzheimers, says senior author Pamela Maher, a research professor and head of Salks Cellular Neurobiology Laboratory. This discovery could one day lead to the development of new therapeutics for treating this disease and other neurodegenerative disorders, like Parkinsons disease.